GIZ Issues Tender for Pharmaceutical GMP Consulting
Consulting firms specializing in sterile manufacturing can now bid to support 6-8 pharmaceutical producers in the SADC region.
Updated on Oct. 16, 2026 in Consumer Goods
Live Poll
Should regional governments prioritize building local pharmaceutical manufacturing capacity to improve access to health commodities?
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) has opened a tender for technical consulting services to assist pharmaceutical manufacturers in the SADC region. The selected firm will guide 6-8 manufacturers toward World Health Organization Good Manufacturing Practice (GMP) compliance.
Why it matters
This initiative aims to improve regional production capacity for sexual and reproductive health commodities by elevating manufacturer readiness for WHO prequalification. Consulting firms must possess specialized expertise in sterile manufacturing and quality systems to participate.
The project targets baseline assessments for 6-8 manufacturers to support WHO prequalification readiness. The contract, identified by reference number 10056248, also requires the delivery of 2 comprehensive GMP capacity-building workshops.
The players
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
A German federal enterprise providing international development services and managing projects on behalf of the German government.
German Federal Ministry for Economic Cooperation and Development
The German government department responsible for international development policy and the funding of external cooperation programs.
European Union
A political and economic union of 27 member states that co-finances international development and infrastructure initiatives.
The details
Consulting firms are tasked with conducting facility-specific gap analyses and developing corrective action roadmaps to meet international manufacturing standards. The core team must include a senior GMP expert, a quality systems specialist, and a sterile manufacturing technician. Proposals must be submitted to the GIZ procurement team by the stated deadline to be considered for the assignment.
Timeline
November 4, 2026, at 17h00: Deadline for bid submission.
Market Landscape
This initiative follows a pattern set by WHO prequalification standards to enhance regional pharmaceutical production reliability. It reflects a broader trend of international development bodies investing in local technical compliance to stabilize supply chains for essential commodities.
Consulting practices should prepare technical teams with sterile manufacturing credentials to meet the November 4 submission deadline. Firms should review tender 10056248 for full compliance requirements regarding facility assessment and training delivery.
The takeaway
Operators in the pharmaceutical consulting sector should monitor GIZ procurement channels for future capacity-building contracts in the SADC region. Firms must ensure all tender documentation is finalized well before the November 4 deadline, as late submissions are strictly prohibited.
Further reading
For broader trends in production standards, visit the Consumer Goods section.
Source note: This article includes information reported by The Mail & Guardian.
Live Poll
Should regional governments prioritize building local pharmaceutical manufacturing capacity to improve access to health commodities?
